Treatment of Tongue Cancer
Surgery is the primary treatment for tongue cancer, with surgical excision recommended for T1-T2 tumors and surgery followed by adjuvant therapy for T3-T4 disease. 1
Initial Evaluation
Before treatment, perform these essential assessments:
- Biopsy for histological confirmation of squamous cell carcinoma 1
- Cervical lymph node evaluation, as approximately 30% of patients present with regional node involvement 1
- CT with contrast and/or MRI of the primary tumor and neck 1
- PET-CT for stage III-IV disease to assess for distant metastases 1
- Baseline voice and swallowing function assessment to guide treatment selection and measure post-treatment outcomes 1
- Dental/prosthodontic evaluation with jaw imaging as indicated 1
Treatment Algorithm by Stage
Early Stage (T1-T2) Disease
Single-modality surgical treatment is recommended to avoid compromising functional outcomes 1, 2:
- Surgical excision of the primary tumor with neck dissection 1
- For anterior tongue cancers, perform bilateral neck dissection due to the 50-60% rate of occult neck metastases 1
- For lateral tongue lesions, ipsilateral neck dissection is typically sufficient unless midline involvement is present 1
- Minimally invasive approaches are preferred when feasible 2
Critical pitfall to avoid: Do not combine surgery with radiotherapy for early-stage disease, as this compromises functional outcomes without survival benefit 1, 2
Advanced Stage (T3-T4) Disease
Surgery followed by adjuvant therapy is the standard approach 1, 3:
- Perform glossectomy (partial, hemi-, or subtotal depending on tumor extent) 3
- Bilateral neck dissection is recommended, preserving the sternocleidomastoid muscle, jugular vein, and spinal accessory nerve when feasible 3
- For T4 tumors, surgical treatment is associated with significantly better survival compared to non-surgical approaches 2, 3
Adjuvant Therapy Guidelines
High-Risk Features Requiring Chemoradiotherapy
Postoperative chemoradiotherapy (Category 1 preferred) is mandatory for 1, 3:
- Extracapsular nodal spread
- Positive mucosal margins
Regimen: Concurrent single-agent cisplatin at 100 mg/m² every 3 weeks 1, 3
Intermediate-Risk Features
Consider postoperative radiotherapy with or without chemotherapy for 1:
- pT3/pT4 primary tumors
- N2/N3 nodal disease
- Nodal disease in levels IV/V
- Perineural invasion
- Vascular tumor embolism
Radiation Delivery
- Deliver radiotherapy to the tumor bed and involved lymph node regions 2
- Escalate dose if microscopically positive margins or extracapsular extension present 2, 3
- Critical timing requirement: Start adjuvant therapy within 6 weeks post-surgery, as delays beyond this timeframe negatively impact outcomes 1, 2, 3
Multidisciplinary Team Requirements
All treatment decisions require multidisciplinary team evaluation including 1:
- Surgical oncology
- Medical oncology
- Radiation oncology
- Speech pathology
- Nutrition/dietetics
- Dental/prosthodontics
- Psychology and rehabilitative services
Integrate nutrition, speech, and swallowing evaluation/therapy throughout the treatment course 1, 3
Functional Outcomes
Advances in microvascular reconstruction techniques have significantly improved functional outcomes after primary surgical management 1, 3
For base of tongue tumors specifically:
- T1-T3 disease: Surgery with or without radiotherapy provides similar local control rates 2
- T4 base of tongue: Combination surgery and radiotherapy may offer advantage, though outcomes remain poor 2, 3
Key Pitfalls to Avoid
- Never delay adjuvant therapy beyond 6 weeks post-surgery - this significantly worsens outcomes 1, 2, 3
- Do not underestimate occult neck metastases risk - anterior tongue cancers have 50-60% occult metastases rate requiring bilateral neck dissection 1
- Avoid combining surgery with radiotherapy for T1-T2 disease - single-modality treatment preserves function without compromising survival 1, 2
- Do not attempt organ preservation in patients with nonfunctional larynx or extensive T4a disease - primary surgery (usually total laryngectomy) is recommended 4